Literature DB >> 19840788

Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.

Hans Lassmann1.   

Abstract

Axonal and neuronal injury and loss are of critical importance for permanent clinical disability in multiple sclerosis patients. Axonal injury occurs already early during the disease and accumulates with disease progression. It is not restricted to focal demyelinated lesions in the white matter, but also affects the normal appearing white matter and the grey matter. Experimental studies show that many different immunological mechanisms may lead to axonal and neuronal injury, including antigen-specific destruction by specific T-cells and auto-antibodies as well as injury induced by products of activated macrophages and microglia. They all appear to be relevant for multiple sclerosis pathogensis in different patients and at different stages of the disease. However, in MS lesions a major mechanism of axonal and neuronal damage appears to be related to the action of reactive oxygen and nitrogen species, which may induce neuronal injury through impairment of mitochondrial function and subsequent energy failure. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19840788     DOI: 10.1016/j.expneurol.2009.10.009

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  63 in total

Review 1.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

Review 2.  CXCL12 in control of neuroinflammation.

Authors:  Miljana Momcilović; Marija Mostarica-Stojković; Djordje Miljković
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia due to multiple sclerosis.

Authors:  N Lummel; J H Mehrkens; J Linn; G Buchholz; R Stahl; K Bochmann; H Brückmann; J Lutz
Journal:  Neuroradiology       Date:  2014-11-18       Impact factor: 2.804

Review 4.  Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.

Authors:  Nabil K El Ayoubi; Samia J Khoury
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

5.  Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin.

Authors:  Antoine Philippe Fournier; Aurélien Quenault; Sara Martinez de Lizarrondo; Maxime Gauberti; Gilles Defer; Denis Vivien; Fabian Docagne; Richard Macrez
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

6.  Focal increases of axoplasmic Ca2+, aggregation of sodium-calcium exchanger, N-type Ca2+ channel, and actin define the sites of spheroids in axons undergoing oxidative stress.

Authors:  Anna G Barsukova; Michael Forte; Dennis Bourdette
Journal:  J Neurosci       Date:  2012-08-29       Impact factor: 6.167

Review 7.  Multiple sclerosis: autoimmunity and viruses.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

8.  Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.

Authors:  Maxime Donadieu; Yann Le Fur; Angèle Lecocq; Andrew A Maudsley; Soraya Gherib; Elisabeth Soulier; Sylviane Confort-Gouny; Fanelly Pariollaud; Marie-Pierre Ranjeva; Jean Pelletier; Maxime Guye; Wafaa Zaaraoui; Bertrand Audoin; Jean-Philippe Ranjeva
Journal:  J Magn Reson Imaging       Date:  2016-01-12       Impact factor: 4.813

Review 9.  Stage-specific immune dysregulation in multiple sclerosis.

Authors:  Benjamin M Segal
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

10.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.